In this episode, we sit down with Dr. Tomoko Maeda-Chubachi - a global leader in dermatology drug development and biotech innovation:

• Dr. Maeda-Chubachi serves as fractional Chief Medical Officer at various startups focusing on dermatology indications.
• 20+ years experience in the pharmaceutical industry, Dr. Maeda-Chubachi has held senior roles at major companies like Pfizer, Eli Lilly, and GSK. Her expertise spans the entire drug development process, from early-phase trials to regulatory approvals.
• Tomoko has multiple notable achievements, she led the FDA approval of Zelsuvmi, helped secure a $250M deal for Vtama, and was named one of 2023’s top CMOs to watch.
• Dr. Maeda-Chubachi is a sought-after speaker, having presented at events like the Dermatology Drug Development Summit and the Japan Biotech Panel. She is also an active member of Women In Bio, receiving the Long Tenure Active Member Award from the RTP chapter.

In this episode, we discuss a range of topics, including her career beginnings, challenges that come with drug development, leadership in biotech, key achievements and much more. This conversation applies broadly to all types of connections in the Life Sciences Industry, and aims to educate and inspire those who want to excel in leadership.

Follow ARTO

LinkedIn: https://www.linkedin.com/company/artotalent

Spotify: Leading Beyond The Lab

Instagram: Instagram (@arto.talent)

TikTok: artotalent on TikTok

Apple Podcasts: Leading Beyond The Lab

Website: Home

Youtube: ARTO Recruitment

Tomoko Maeda-Chubachi

CMO at Kalm Therapeutics + Boardroom Ready at Women in Bio

LinkedIn: https://www.linkedin.com/in/tomoko-maeda-chubachi/

Lawrence Rose

Co-Founder + Talent Solutions Director At ARTO

LinkedIn: https://www.linkedin.com/in/lawrencerose/

Timestamps:

00:00 Career Beginnings

06:23 Drug Development

08:59 Leadership

13:58 Achievements + Fractional CMO

#LeadingBeyondTheLab #ARTOTalent #Biotechnology #Dermatology

Hosted on Acast. See acast.com/privacy for more information.